<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Gu Y</submitter><funding>National Natural Science Foundation of China</funding><pagination>2378210</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11299449</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>46(2)</volume><pubmed_abstract>&lt;b>Objectives:&lt;/b> To explore the therapeutic effects of M2 macrophages in diabetic nephropathy (DN) and their mechanism.&lt;b>Methods:&lt;/b> We infused M2 macrophages stimulated with IL-4 into 10-week-old db/db mice once a week for 4 weeks through the tail vein as M2 group. Then we investigated the role of M2 macrophages in alleviating the infammation of DN and explored the mechanism.&lt;b>Results:&lt;/b> M2 macrophages hindered the progression of DN, reduced the levels of IL-1β (DN group was 34%, M2 group was 13%, &lt;i>p&lt;/i> &lt; 0.01) and MCP-1 (DN group was 49%, M2 group was 16%, &lt;i>p&lt;/i> &lt; 0.01) in the glomeruli. It was also proven that M2 macrophages alleviate mesangial cell injury caused by a high glucose environment. M2 macrophage tracking showed that the infused M2 macrophages migrated to the kid</pubmed_abstract><journal>Renal failure</journal><pubmed_title>M2 macrophage infusion ameliorates diabetic glomerulopathy &lt;i>via&lt;/i> the JAK2/STAT3 pathway in db/db mice.</pubmed_title><pmcid>PMC11299449</pmcid><funding_grant_id>81870578</funding_grant_id><pubmed_authors>Yin Y</pubmed_authors><pubmed_authors>Liu J</pubmed_authors><pubmed_authors>Gu Y</pubmed_authors><pubmed_authors>Yu S</pubmed_authors><pubmed_authors>Lyu Z</pubmed_authors><pubmed_authors>Mu Y</pubmed_authors><pubmed_authors>Gu W</pubmed_authors><pubmed_authors>Zhang H</pubmed_authors><pubmed_authors>Yuan M</pubmed_authors><pubmed_authors>Guo Q</pubmed_authors><pubmed_authors>Zhang Q</pubmed_authors><pubmed_authors>Cheng Y</pubmed_authors><pubmed_authors>Li B</pubmed_authors><pubmed_authors>Xue J</pubmed_authors></additional><is_claimable>false</is_claimable><name>M2 macrophage infusion ameliorates diabetic glomerulopathy &lt;i>via&lt;/i> the JAK2/STAT3 pathway in db/db mice.</name><description>&lt;b>Objectives:&lt;/b> To explore the therapeutic effects of M2 macrophages in diabetic nephropathy (DN) and their mechanism.&lt;b>Methods:&lt;/b> We infused M2 macrophages stimulated with IL-4 into 10-week-old db/db mice once a week for 4 weeks through the tail vein as M2 group. Then we investigated the role of M2 macrophages in alleviating the infammation of DN and explored the mechanism.&lt;b>Results:&lt;/b> M2 macrophages hindered the progression of DN, reduced the levels of IL-1β (DN group was 34%, M2 group was 13%, &lt;i>p&lt;/i> &lt; 0.01) and MCP-1 (DN group was 49%, M2 group was 16%, &lt;i>p&lt;/i> &lt; 0.01) in the glomeruli. It was also proven that M2 macrophages alleviate mesangial cell injury caused by a high glucose environment. M2 macrophage tracking showed that the infused M2 macrophages migrated to the kid</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Dec</publication><modification>2025-04-05T15:02:52.712Z</modification><creation>2025-02-19T04:41:01.013Z</creation></dates><accession>S-EPMC11299449</accession><cross_references><pubmed>39090966</pubmed><doi>10.1080/0886022X.2024.2378210</doi></cross_references></HashMap>